How far does cancer prevention depend on shareholder democracy?

The American Cancer Society identifies tobacco as the leading preventable cause of cancer, responsible for about 20% of all cancer deaths and about 80% of lung cancer deaths.

Tobacco companies manufacture, market, and lobby for the product that the American Cancer Society calls the single largest preventable cause of cancer death. Corporate conduct here means what companies make and how they sell it; corporate political influence means their spending to weaken warning labels, marketing restrictions, and taxation. Shareholder votes can press tobacco companies to shift toward reduced-risk products and to curb lobbying against public health measures. But tobacco use is ultimately a personal behavior, and the largest reductions in smoking rates in the United States have come from state taxes, clean-air laws, and public health campaigns rather than from corporate self-reform. Owner votes can accelerate change at the margin and remove political blocking, but governments and households must also move. The rating is Necessary because shareholder democracy can remove an obstacle nothing else removes, yet it is not sufficient alone.

The American Cancer Society estimates that excess body weight, physical inactivity, and poor nutrition contribute to about 18% of cancer cases, with obesity linked to at least 13 cancer types.

Food and beverage companies formulate, market, and distribute the ultra-processed products and sugary drinks that contribute to obesity, which the American Cancer Society links to rising cancer incidence. Corporate conduct matters here: reformulating products, reducing portion sizes, and changing marketing practices can help. But diet and exercise are fundamentally household choices, shaped by culture, income, education, and built environment more than by any single company's conduct. Corporate political influence on nutrition policy exists but is not the primary obstacle to better diets. Shareholder votes can encourage food companies to improve their product portfolios and marketing, yet the critical path runs through public health education, school meal programs, urban planning, and healthcare counseling. The rating is Helpful because owner votes can assist at the margin but do not sit on the critical path.

The International Agency for Research on Cancer classifies over 100 agents as carcinogenic to humans, with occupational exposures estimated to cause 3-6% of all cancers; the National Institute for Occupational Safety and Health emphasizes preventable workplace exposures.

Chemical manufacturers, industrial users, and employers decide what carcinogens enter workplaces and communities, and industry lobbying has repeatedly weakened or delayed standards for asbestos, benzene, formaldehyde, and other confirmed carcinogens. Corporate conduct is decisive: substituting safer chemicals, improving ventilation, and disclosing exposures can prevent cancer directly. Corporate political influence is blocking: the American Chemistry Council and individual firms have lobbied against stricter EPA standards under the Toxic Substances Control Act and OSHA permissible exposure limits. Shareholder votes can press companies to eliminate carcinogen use and to stop lobbying against stronger regulation. Where companies control the exposure and the political opposition, owner votes can deliver most of the outcome. The rating is Pivotal because the obstacle sits in corporate conduct and corporate lobbying together.

The International Agency for Research on Cancer estimates that infectious agents cause about 15% of cancers globally, including HPV-related cervical cancer and hepatitis B-related liver cancer, with vaccines available for prevention.

Pharmaceutical companies manufacture HPV and hepatitis B vaccines, but access barriers are price, distribution infrastructure, healthcare coverage, and vaccine hesitancy rather than corporate conduct or lobbying. Gavi, the Vaccine Alliance, and national immunization programs have driven global access; in the United States, the Affordable Care Act mandates coverage without cost-sharing. Corporate political influence is not a significant obstacle to infectious-agent cancer prevention. Where companies have engaged in conduct that matters, such as pricing disputes, the critical path still runs through government procurement, international aid, and public health delivery systems. The rating is Independent because the obstacle belongs to governments, international organizations, and households, not to corporate conduct or political spending.

The International Agency for Research on Cancer classifies ultraviolet-emitting tanning devices as Group 1 carcinogens; melanoma incidence has risen steadily, with indoor tanning before age 30 increasing melanoma risk by 75%.

Indoor tanning companies operate the devices that cause preventable skin cancer, and their marketing targets young people. Corporate conduct matters: companies could restrict access by minors, improve warnings, and shift to sunless alternatives. But indoor tanning is a consumer choice, and the most effective interventions have been state laws banning minor access and taxing tanning services. The industry is fragmented and small relative to other cancer causes, limiting the reach of shareholder advocacy. Corporate political influence exists at the state level but is not a primary national obstacle. The rating is Helpful because owner votes can encourage better practices at the margin, but the critical path runs through state legislation and consumer behavior change.

The International Agency for Research on Cancer classifies alcohol as a Group 1 carcinogen, with alcohol use linked to cancers of the mouth, throat, esophagus, liver, breast, and colorectum; alcohol contributes to about 6% of all cancers.

Alcohol producers manufacture, market, and distribute the carcinogen, and their lobbying has resisted warning labels, marketing restrictions, and taxation increases that reduce consumption. Corporate conduct matters: producers could reformulate to lower alcohol content, improve labeling, and reduce marketing. But alcohol consumption is a personal and cultural behavior, and the largest reductions in alcohol-related harm have come from taxation, licensing laws, and social norms rather than from corporate self-regulation. The industry's political influence is real but less blocking than in tobacco. The rating is Helpful because shareholder votes can encourage better corporate practices but do not sit on the critical path for population-level cancer prevention.

The American Cancer Society identifies hormonal factors including reproductive history, hormone replacement therapy, and fertility treatments as significant contributors to breast, ovarian, and endometrial cancer risk.

Pharmaceutical companies manufacture hormone therapies and fertility drugs, but the cancer risk trade-offs are medical decisions made by patients and physicians, not corporate conduct problems. Companies do not lobby to promote unsafe hormone use; regulatory agencies approve products with labeled risks. The obstacle to better outcomes is healthcare access, patient education, and research into safer alternatives, not corporate political blocking or product design. Where companies have conducted research or marketed aggressively, the critical path still runs through clinical practice guidelines, FDA oversight, and informed patient choice. The rating is Independent because the obstacle belongs to healthcare systems, researchers, and households, not to corporate conduct or lobbying.

The National Cancer Institute identifies aging as the most important risk factor for cancer overall, with median age at diagnosis of 66 years; about 25% of new cancer diagnoses occur in people aged 65 to 74.

Aging is a biological process, not a corporate choice, and no company's conduct or lobbying accelerates or prevents it. Pharmaceutical and biotechnology companies research aging biology and age-related cancer therapies, but their conduct does not create the obstacle and their lobbying does not block its resolution. The critical path to addressing age-related cancer risk runs through basic scientific research funded by NIH and international equivalents, through healthcare systems that manage comorbidities, and through public health measures that reduce lifetime exposure to other risk factors. The rating is Independent because this obstacle belongs to science, medicine, and demographics, not to corporate conduct or political influence.